Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

NCT02710370 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT02710370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02710370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Active, not recruiting
Start date
February 29, 2016
Completion date
August 31, 2028
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, endocrine system diseases, glucose metabolism disorders, metabolic diseases, obesity